Newsroom
Sorted by: Latest
-
VENU CEO J.W. Roth Featured on The Business Digest Radio Show & Podcast
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Venu Holding Corporation ("VENU" or the "Company") (NYSE AMERICAN: VENU), an owner, operator, and developer of premium live entertainment destinations, today announced that Founder, Chairman, and CEO J.W. Roth was featured in an in-depth interview with executive publisher and host Dirk Hobbs, CEO of Colorado Media Group, on The Business Digest Radio Show & Podcast; the radio and podcast outreach of the Southern Colorado Business Digest. In the conve...
-
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy
TOKYO--(BUSINESS WIRE)--Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sanky...
-
Best’s Market Segment Report: U.S. Cyber Market’s Premium Grows Slightly; Surplus Lines Writers Continue to Increase Role
OLDWICK, N.J.--(BUSINESS WIRE)--A pair of distinct sub-markets have evolved within the U.S. cyber insurance space, one dominated by surplus lines carriers writing primary and excess cyber-specific policies and the other focused on endorsements to commercial policies, according to a new AM Best report. The results between the two vary, with third-party claims growing more rapidly within the surplus lines side of the market.The combined overall premiums generated from cyber insurance coverage incr...
-
Ermenegildo Zegna Group Reports Voting Results of the Annual General Meeting Held on June 26, 2026
MILAN--(BUSINESS WIRE)--Ermenegildo Zegna N.V. (NYSE:ZGN) (the “Company” and, together with its consolidated subsidiaries, the “Ermenegildo Zegna Group” or the “Group”) announced that all resolutions submitted to the annual general meeting held on June 26, 2026 were adopted, including, among others: the proposal to approve a dividend distribution of EUR 0.12 per ordinary share, corresponding to a total dividend distribution on the outstanding ordinary shares of approximately EUR 32 million1. th...
-
Burjeel Holdings precifica primeiro Sukuk do setor de saúde na região MENA desde 2018; demanda supera a oferta em 3,2 vezes
ABU DHABI, EAU--(BUSINESS WIRE)--A Burjeel Holdings, grupo líder em saúde de super especialidades no GCC (Conselho de Cooperação do Golfo) com cotação na Bolsa de Valores de Abu Dhabi, precificou sua oferta inaugural de Sukuk sênior sem garantia no valor de US$ 500 milhões nos termos do Regulamento S, com prazo de 5 anos e vencimento em 2031, sob seu recém-criado Programa de Sukuk Sênior Sem Garantia de US$ 1,5 bilhão. A oferta atraiu demanda significativa de investidores internacionais e regio...
-
Burjeel Holdings、中東・北アフリカ(MENA)地域で2018年以来初となる医療分野のスクークを発行、募集額の3.2倍の応募を集める
アラブ首長国連邦 アブダビ--(BUSINESS WIRE)--(ビジネスワイヤ) -- アブダビ証券取引所に上場する湾岸協力会議(GCC)地域有数の高度専門医療グループであるBurjeel Holdingsは、新たに設立した総額15億米ドルのシニア無担保スクーク・プログラムに基づき、2031年満期のRegulation S適格の5年物シニア無担保スクーク(イスラム債)5億米ドルの初回発行について、発行条件を決定しました。 本スクークには、質の高い海外および地域の投資家からの強い需要が集まり、受注額はピーク時に16億米ドルに達し、募集額の3.2倍の応募となりました。こうした堅調な需要を受け、Burjeel Holdingsは当初提示していた7%台半ばの価格ガイダンスから条件を引き締めることができ、最終的に本スクークは利益率7.000%、利回り7.125%で条件が決定されました。これは、GCC地域に本拠を置く投資適格未満の民間企業による5年債としては、2020年以降で最低の利回りとなります。 最終配分では、海外投資家が全体の61%を占め、その内訳は英国の投資家が34%、米国オフショア投...
-
Citibank UK Regulatory Announcement: Early Redemption(s)
LONDON--(BUSINESS WIRE)-- Please be advised that the following issue has redeemed early: ISIN: XS2280537916 Issuer: NCB Tier 1 Sukuk Limited Call Date: 27/07/2026 Amount Redeeming: USD 1,250,000,000 Call Price: 100%...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100® Moderate Buffer UCITS ETF - March 25.06.2026 QMAR.LN IE0006S0EBF2 50,002.00 USD 1,234,554.71 24.690 ...
-
DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Artificial Intelligence UCITS ETF 25.06.2026 FTAI IE000YIQZ0H6 200,002.00 USD 6,007,593.28 30.038 ...